SUBSCRIBE
SUBSCRIBE

TG Therapeutics, Inc.

NEWS
Drug Development
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
February 20, 2024
 · 
14 min read
Business
Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases
February 12, 2024
 · 
8 min read
Business
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones
January 10, 2024
 · 
15 min read
Business
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
January 9, 2024
 · 
10 min read
Business
TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision’s Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune Diseases
January 9, 2024
 · 
5 min read
Pharm Country
TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferencePresentation scheduled for Tuesday, January 9, 2024, at 4:30 PM PT
January 5, 2024
 · 
1 min read
Pharm Country
TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceFireside chat scheduled for Wednesday, November 29, 2023, at 2:10 PM ET
November 27, 2023
 · 
1 min read
Pharm Country
TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) ConferenceFireside chat scheduled for Monday, November 6, 2023, at 3:10 PM ET
November 3, 2023
 · 
1 min read
Business
TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
November 1, 2023
 · 
19 min read
Business
TG Therapeutics to Host Conference Call on Third Quarter 2023 Financial Results and Business UpdateConference call to be held Wednesday, November 1, 2023, at 8:30 AM ET
October 30, 2023
 · 
1 min read
Pharm Country
TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
October 11, 2023
 · 
13 min read
Drug Development
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
October 2, 2023
 · 
14 min read
Pharm Country
TG Therapeutics to Participate in the 2023 Cantor Global Healthcare ConferenceFireside chat scheduled for Tuesday, September 26, 2023, at 12:25 PM ET
September 22, 2023
 · 
1 min read
Pharm Country
TG Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceFireside chat scheduled for Monday, September 11, 2023, at 10:30 AM ET
September 7, 2023
 · 
1 min read
Business
TG Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
August 1, 2023
 · 
20 min read
Business
TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy)
August 1, 2023
 · 
17 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
JOBS